| 1 |
31479709 | Modulation of FLT3 through decitabine-activated C/EBPa-PU.1 signal pathway in FLT3-ITD positive cells. | 2019 Dec |
4 |
| 2 |
29305415 | Histone modifier gene mutations in peripheral T-cell lymphoma not otherwise specified. | 2018 Apr |
1 |
| 3 |
29766990 | Correction: Chidamide and decitabine can synergistically induce apoptosis of Hodgkin lymphoma cells by up-regulating the expression of PU.1 and KLF4. | 2018 Apr 20 |
1 |
| 4 |
29100410 | Chidamide and decitabine can synergistically induce apoptosis of Hodgkin lymphoma cells by up-regulating the expression of PU.1 and KLF4. | 2017 Sep 29 |
2 |
| 5 |
24944809 | The differentiation effect of low-dose cytosine arabinoside is disturbed in PU.1-knockdown K562 cells. | 2014 Jul |
3 |
| 6 |
22459451 | The differentiating and apoptotic effects of 2-aza-5'-deoxycytidine are dependent on the PU.1 expression level in PU.1-transgenic K562 cells. | 2012 Apr 20 |
2 |
| 7 |
20501800 | Decitabine maintains hematopoietic precursor self-renewal by preventing repression of stem cell genes by a differentiation-inducing stimulus. | 2010 Jun |
1 |
| 8 |
19769942 | Escape mechanisms from antibody therapy to lymphoma cells: downregulation of CD20 mRNA by recruitment of the HDAC complex and not by DNA methylation. | 2009 Dec 4 |
1 |
| 9 |
17586044 | PU.1 is dispensable to block erythroid differentiation in Friend erythroleukemia cells. | 2008 Jan |
2 |
| 10 |
17203216 | Decitabine and vitamin D3 differentially affect hematopoietic transcription factors to induce monocytic differentiation. | 2007 Feb |
1 |
| 11 |
17545613 | Down-regulation of PU.1 by methylation of distal regulatory elements and the promoter is required for myeloma cell growth. | 2007 Jun 1 |
1 |